Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Derfler v. Illumina, Inc. et al
Case Number:
3:12-cv-00564
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
July 31, 2012
Illumina, Investor Drop Fight Over Poison Pill In Roche Bid
Gene sequencing company Illumina Inc. and one of its shareholders agreed Monday to resolve the investor's suit, which he had intended to use as an antidote to Illumina's poison pill efforts to block Roche Holding AG's hostile takeover attempt.
-
March 07, 2012
Investor Fights Illumina's Poison Pill Against Roche Bid
Gene-sequencing firm Illumina Inc. was hit Tuesday with a proposed shareholder class action intended as an antidote to the company's recent poison pill efforts to resist a hostile takeover by Roche Holding AG.